Connection

Kevin Gray to Central Nervous System Stimulants

Back to Details
This is a "connection" page, showing publications Kevin Gray has written about Central Nervous System Stimulants.
Kevin Gray
Connection Strength
0.344
Central Nervous System Stimulants
  1. Brain iron levels in attention-deficit/hyperactivity disorder normalize as a function of psychostimulant treatment duration. Neuroimage Clin. 2019; 24:101993.
    View in: PubMed
    Score: 0.143
  2. Multimodal MR imaging of brain iron in attention deficit hyperactivity disorder: a noninvasive biomarker that responds to psychostimulant treatment? Radiology. 2014 Aug; 272(2):524-32.
    View in: PubMed
    Score: 0.100
  3. Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders. Drug Alcohol Depend. 2011 Sep 01; 117(2-3):242-7.
    View in: PubMed
    Score: 0.080
  4. Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav. 2011 Aug; 99(2):285-94.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.